AI Generated Image
VA announces launch of GLP-1 treatment to help veterans struggling with alcohol
National Desk • • general
Key Points:
- The VA announced a clinical trial to evaluate the effectiveness of GLP-1 receptor treatment for veterans with diabetes and alcohol use disorder (AUD).
- GLP-1 medications have previously shown promise in reducing substance abuse and emergency room visits.
- The trial, named Cessation or Reduction of Alcohol Consumption in Veterans, will enroll 600 veterans across 18 VA medical centers.
- Researchers will monitor changes in participants’ drinking habits, health, and quality of life after receiving GLP-1 injections.
- Recruitment for the study begins on July 28, 2026, and veterans interested can contact their local VA center or visit ClinicalTrials.gov for more information.
